Flanders.bio appoints new management team to step up its strategy


To further support the execution of its strategic plan, flanders.bio is pleased to announce it has successfully strengthened its management team

flanders.bio today announced that it has strengthened its management team in view of the execution of its ambitious strategic plans. In its continued support of the growth and maturation of the unique life sciences sector in Flanders and Belgium, the Board of Directors of flanders.bio has chosen to appoint two directors with complementary profiles, experiences and capabilities being Willem Dhooge and Pascale Engelen.

Willem Dhooge has been a key member of the team in the growth of flanders.bio from a 20-company member organisation in 2006 to the 340 members it represents today. Willem Dhooge will continue to assist life sciences companies in the early phases of their development, stimulating collaborative research, opening to new technologies, and connecting with all R&D actors in the region and country.

Pascale Engelen will join the team as second director and brings more than 25 years of senior management experience in the life sciences industry including leading positions in big pharma companies (Wyeth, Mylan) as well as small companies. She will focus on all aspects of company scale-up and growth, including the test and trial phases of product development, the access to risk capital and the development of specific human capital assets in the region and country. She will also develop our international and government relationship strategy.

Together Pascale and Willem will stimulate the further evolution of Flanders and Belgium as one of the most successful life sciences regions in Europe, and build its reputation as the ideal ecosystem for international companies to set-up their business and fully exploit their European market potential.

Willem Dhooge says: "The life sciences sector worldwide is facing many challenges, but also bears many opportunities to develop new product types for the benefit of patients, farmers and consumers. With the knowledge for growth conference, and the diverse set of new cross disciplinary platforms we are developing, I am convinced that we can make substantial contributions in the coming years to stimulate the life sciences sector in our region to grow to its full potential”.

Pascale Engelen complements: “flanders.bio is entering a new exciting phase in its strategy to further support and grow the Flemish Life Sciences Cluster. I’m really looking forward to working with flanders.bio’s team, its board, its members and strategic partners in creating a vibrant and collaborative ecosystem that enables our members to maximize their performance. Accelerating the bio-based development testing path, facilitating access to equity and smart funding, and attracting the best people will be key assets to create winners”.


Over the past years, flanders.bio has moved from a pioneering role representing, promoting and connecting biotechnology companies to a more content driven organisation and key player in the life sciences ecosystem.

Dirk Reyn, Vice Chairman said: “With the new strategy, we have started to strengthen capabilities at different levels of our organisation and with the stronger management team we can turn these priorities into strategic actions. The board recognized that a different type of organisation is required going forward and we feel we have found complementary skills in Willem and Pascale. Their predecessor, Henk Joos can be proud of the progress the team has made to help us take the organisation to this tipping point”.

Erwin Blomsma, Chairman: “We want to welcome Pascale to our organisation and reward Willem with this step for his long-time contributions to flanders.bio. We also want to thank Henk Joos very much for all his effort in further growing flanders.bio since he took over. These efforts have resulted in a growing attendance at our events like knowledge for growth; the expansion of the scope of our activities and an even broader global network of partners.


flanders.bio is a dynamic, member driven organisation with currently more than 340 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise.

flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.

flanders.bio is supported by a number of strategic partners: VIB, Janssen Pharmaceutica, Roche Diagnostics, KBC Securities, CMAST, Flanders Investment & Trade, Agentschap Innoveren & Ondernemen and Gimv.

For more info, please visit www.flanders.bio.
flanders.bio, an independent life sciences cluster organisation based in Flanders (Belgium), keeps the media informed about the biotech & life sciences news of its member companies.



Interested in a regular update of the Life Sciences and biotech sector in Flanders?